Sunesis Pharmaceuticals Inc. (NASDAQ: SNSS) is at it again. The company more than doubled yesterday to $1.39 on over 35 million based upon Tuesday’s leukemia Phase II drug news presented this week. Traders and investors are speculating that this could be the next small-cap low priced stock that could be a ten-bagger in biotech. Shares are up 7% at $1.49 on 840,000 shares as of 8:26 AM EST. The year high was put in yesterday at $1.84 and even after the price doubled its market cap at yesterday’s close was a mere $47.8 million.
Jon C. Ogg
No comments:
Post a Comment